PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
23-May-2024 M1 Kliniken AG: Strong profit growth in 2023 underlines ambitious plans for global market leadership in medical aesthetics M1 Kliniken AG
23-May-2024 Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business Gerresheimer AG
23-May-2024 DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025 DocMorris AG
23-May-2024 Galenica on track with sales growth Galenica AG
23-May-2024 Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed Gerresheimer AG
22-May-2024 Marinomed Biotech AG announces results for the first quarter of 2024 Marinomed Biotech AG
22-May-2024 Evotec reports Q1 2024 results and provides corporate update Evotec SE
21-May-2024 Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM Sanofi
21-May-2024 Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration Sanofi
20-May-2024 First pharma signatory of the Pitch Positive Pledge! PM Society
17-May-2024 Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast Sartorius Stedim Biotech SA
17-May-2024 STRATEC ANNUAL GENERAL MEETING ADOPTS RESOLUTION ON DIVIDEND AND APPROVES ALL AGENDA ITEMS STRATEC SE
17-May-2024 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE
16-May-2024 The PM Society announces that Sumira Riaz will join Christine Buggle as co-Chair of the Patient Engagement Interest Group in 2024 The PM Society
16-May-2024 Veranova and Phorum.AI Partner to Deliver Generative AI Chemistry Optimization to the Pharmaceutical & Biotech Industry Veranova
16-May-2024 Newron reports compelling additional data documenting the efficacy of evenamide in pivotal study 008A in poorly responding schizophrenia patients Newron Pharmaceuticals
15-May-2024 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial Ascendis Pharma A/S
15-May-2024 HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China HUTCHMED
15-May-2024 HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui HUTCHMED
15-May-2024 Evotec SE to announce results for first quarter 2024 on 22 may 2024 Evotec SE